Genevation: Revolutionizing Cancer Therapy with Precision Oncology
At Genevation, we are transforming the landscape of cancer therapy through innovation. Established in 2022 in London, United Kingdom, we are a pioneering pre-clinical stage biotechnology company dedicated to developing personalized cancer vaccines and mRNA-based therapeutics. We have developed personalized Cancer Vaccines in two-weeks time for our pre-clinical trials.
Our approach combines cutting-edge technology, such as AI-driven neoantigen discovery and advanced cell-free manufacturing platforms, to accelerate the development of precision oncology solutions tailored to individual patients.
In 2024, we expanded globally with the launch of a state-of-the-art subsidiary in San Diego, California, bolstering our R&D and manufacturing capabilities to bring ground breaking therapies closer to reality.
Join us in our mission to redefine cancer treatment and create a future where precision medicine transforms lives.
Follow us for updates on our journey toward a new era in oncology.
#Biotechnology #CancerResearch #mRNA #PrecisionOncology #Innovation
Company Details
- Employees
- 2
- Founded
- -
- Address
- Gunnels Wood Rd, Stevenage,sg1 2fx,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://genevation.co.uk
- HQ
- Stevenage
Genevation Ltd Questions
Genevation Ltd's website is http://genevation.co.uk
Genevation Ltd's LinkedIn profile is https://www.linkedin.com/company/genevation-ltd
Genevation Ltd has
2 employees.
View email and phone details for 2
employees at Genevation Ltd.
Genevation Ltd's industry is
Biotechnology Research
Genevation Ltd's top competitors are
Genehub,
Vasodynamics Ltd,
Genomics England,
Aiknit,
Kestrix,
Bioarchitech Ltd,
Magic Ai,
Antikor Biopharma Ltd,
Pear Bio,
Catalystbio.
Genevation Ltd's categories are Biotechnology Research
Genevation Ltd's founding year is 2022
